Search Results for: HSPA8

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
RAF1 Raf-1 proto-oncogene, serine/threonine kinase
  • Stimuli-sensing channels
  • Rap1 signalling
  • GP1b-IX-V activation signalling
  • CD209 (DC-SIGN) signaling
  • RAF activation
  • MAP2K and MAPK activation
  • Negative feedback regulation of MAPK pathway
  • Negative regulation of MAPK pathway
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • SHOC2 M1731 mutant abolishes MRAS complex function
  • Gain-of-function MRAS complexes activate RAF signaling
  • IFNG signaling activates MAPKs
  • Sorafenib
  • LErafAON
  • XL281
  • iCo-007
  • Cholecystokinin
  • Regorafenib
  • Dabrafenib
  • Fostamatinib
RB1 RB transcriptional corepressor 1
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Condensation of Prophase Chromosomes
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Oncogene Induced Senescence
  • Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes
  • Cyclin E associated events during G1/S transition
  • Cyclin D associated events in G1
  • Cyclin A:Cdk2-associated events at S phase entry
  • RUNX2 regulates osteoblast differentiation
  • Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
  • Defective translocation of RB1 mutants to the nucleus
  • Replication of the SARS-CoV-1 genome
  • Aberrant regulation of mitotic exit in cancer due to RB1 defects
  • Replication of the SARS-CoV-2 genome
  • Nuclear events stimulated by ALK signaling in cancer
  • Positive Regulation of CDH1 Gene Transcription
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • Chronic myeloid leukemia (CML)
  • Breast cancer
  • Osteosarcoma
  • Hepatocellular carcinoma
  • Small cell lung cancer
  • Esophageal cancer
  • Glioma
  • Bladder cancer
REL REL proto-oncogene, NF-kB subunit
  • Activation of NF-kappaB in B cells
  • Hodgkin lymphoma
RGS2 regulator of G protein signaling 2
  • G alpha (q) signalling events
RNF26 ring finger protein 26
SAYSD1 SAYSVFN motif domain containing 1
SIRPA signal regulatory protein alpha
  • Cell surface interactions at the vascular wall
  • Signal regulatory protein family interactions
  • Signal regulatory protein family interactions
  • Neutrophil degranulation
SNCA synuclein alpha
  • Amyloid fiber formation
  • PKR-mediated signaling
  • Resveratrol
  • Dequalinium
  • Copper
  • Lewy body dementia (LBD); Dementia with Lewy bodies (DLB)
  • Parkinson's disease (PD)
SP1 Sp1 transcription factor
  • PPARA activates gene expression
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Activation of gene expression by SREBF (SREBP)
  • Oncogene Induced Senescence
  • RNA polymerase II transcribes snRNA genes
  • RNA polymerase II transcribes snRNA genes
  • Estrogen-dependent gene expression
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • Regulation of CDH11 gene transcription
  • Regulation of CDH11 gene transcription
  • Positive Regulation of CDH1 Gene Transcription
  • NFE2L2 regulating tumorigenic genes
  • TGFBR3 expression
SRRT serrate, RNA effector molecule
  • RNA polymerase II transcribes snRNA genes
  • mRNA Splicing - Major Pathway
  • Nuclear RNA decay
ST13 ST13 Hsp70 interacting protein
  • Regulation of HSF1-mediated heat shock response
STAT1 signal transducer and activator of transcription 1
  • Interleukin-6 signaling
  • ISG15 antiviral mechanism
  • Signaling by SCF-KIT
  • Signaling by cytosolic FGFR1 fusion mutants
  • Downstream signal transduction
  • Interleukin-4 and Interleukin-13 signaling
  • Interleukin-20 family signaling
  • Regulation of RUNX2 expression and activity
  • Interleukin-35 Signalling
  • Interleukin-9 signaling
  • NOTCH3 Intracellular Domain Regulates Transcription
  • NOTCH3 Intracellular Domain Regulates Transcription
  • Interleukin-27 signaling
  • Interleukin-21 signaling
  • Interferon alpha/beta signaling
  • Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Signaling by CSF3 (G-CSF)
  • Signaling by CSF1 (M-CSF) in myeloid cells
  • Inactivation of CSF3 (G-CSF) signaling
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
  • Signaling by ALK fusions and activated point mutants
  • Growth hormone receptor signaling
  • PKR-mediated signaling
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • Regulation of PD-L1(CD274) transcription
  • Chronic Mucocutaneous Candidiasis (CMC); Familial candidiasis (CANDF)
  • IFN-gamma/IL-12 axis, including the following five diseases: IL-12 p40 subunit deficiency; IL-12 receptor (IL-12R) beta1 chain deficiency; IFN-gamma receptor (IFN gamma R) alpha chain deficiency; IFN-gamma receptor (IFN gamma R) beta chain deficiency; STAT-1 deficiency
STIP1 stress induced phosphoprotein 1
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • RND1 GTPase cycle
  • Copper
STMN1 stathmin 1
  • Nuclear signaling by ERBB4
STUB1 STIP1 homology and U-box containing protein 1
  • Downregulation of TGF-beta receptor signaling
  • RIPK1-mediated regulated necrosis
  • Regulation of TNFR1 signaling
  • Regulation of necroptotic cell death
  • Downregulation of ERBB2 signaling
  • Regulation of RUNX2 expression and activity
  • Regulation of PTEN stability and activity
  • Antigen processing: Ubiquitination & Proteasome degradation
SUMO2 small ubiquitin like modifier 2
  • Vitamin D (calciferol) metabolism
  • SUMO is conjugated to E1 (UBA2:SAE1)
  • SUMO is transferred from E1 to E2 (UBE2I, UBC9)
  • SUMO is proteolytically processed
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of transcription factors
  • SUMOylation of transcription cofactors
  • SUMOylation of SUMOylation proteins
  • SUMOylation of intracellular receptors
  • SUMOylation of intracellular receptors
  • SUMOylation of chromatin organization proteins
  • SUMOylation of RNA binding proteins
  • SUMOylation of DNA replication proteins
  • Processing of DNA double-strand break ends
  • Formation of Incision Complex in GG-NER
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
SUMO4 small ubiquitin like modifier 4
TADA3 transcriptional adaptor 3
  • HATs acetylate histones
  • Ub-specific processing proteases
  • Formation of WDR5-containing histone-modifying complexes
TCERG1 transcription elongation regulator 1
  • mRNA Splicing - Major Pathway
TGM2 transglutaminase 2
  • Guanosine-5'-Diphosphate
  • Hexylresorcinol

Page 4 out of 5 pages